BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 12029119)

  • 1. HIV/AIDS. HLA leaves its footprints on HIV.
    McMichael A; Klenerman P
    Science; 2002 May; 296(5572):1410-1. PubMed ID: 12029119
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level.
    Moore CB; John M; James IR; Christiansen FT; Witt CS; Mallal SA
    Science; 2002 May; 296(5572):1439-43. PubMed ID: 12029127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic T lymphocyte epitopes shared between HIV-1, HIV-2, and SIV.
    Gotch F; Nixon D; Gallimore A; McAdam S; McMichael A
    J Med Primatol; 1993; 22(2-3):119-23. PubMed ID: 7692055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV escape: there and back again.
    Altman JD; Feinberg MB
    Nat Med; 2004 Mar; 10(3):229-30. PubMed ID: 14991039
    [No Abstract]   [Full Text] [Related]  

  • 5. Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection.
    Allen TM; Altfeld M; Yu XG; O'Sullivan KM; Lichterfeld M; Le Gall S; John M; Mothe BR; Lee PK; Kalife ET; Cohen DE; Freedberg KA; Strick DA; Johnston MN; Sette A; Rosenberg ES; Mallal SA; Goulder PJ; Brander C; Walker BD
    J Virol; 2004 Jul; 78(13):7069-78. PubMed ID: 15194783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-specific cytotoxic T-lymphocyte cross-recognition of naturally occurring variants of a human immunodeficiency virus type 1 (HIV-1) p24gag epitope by HIV-1-infected children.
    Buseyne F; Chaix ML; Rouzioux C; Blanche S; Rivière Y
    J Virol; 2001 May; 75(10):4941-6. PubMed ID: 11312369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple transmissions of a stable human leucocyte antigen-B27 cytotoxic T-cell-escape strain of HIV-1 in The Netherlands.
    Cornelissen M; Hoogland FM; Back NK; Jurriaans S; Zorgdrager F; Bakker M; Brinkman K; Prins M; van der Kuyl AC
    AIDS; 2009 Jul; 23(12):1495-500. PubMed ID: 19487902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTL ontogeny and viral escape: implications for HIV-1 vaccine design.
    Yang OO
    Trends Immunol; 2004 Mar; 25(3):138-42. PubMed ID: 15036041
    [No Abstract]   [Full Text] [Related]  

  • 9. Reversion of CTL escape-variant immunodeficiency viruses in vivo.
    Friedrich TC; Dodds EJ; Yant LJ; Vojnov L; Rudersdorf R; Cullen C; Evans DT; Desrosiers RC; Mothé BR; Sidney J; Sette A; Kunstman K; Wolinsky S; Piatak M; Lifson J; Hughes AL; Wilson N; O'Connor DH; Watkins DI
    Nat Med; 2004 Mar; 10(3):275-81. PubMed ID: 14966520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes.
    Murakoshi H; Akahoshi T; Koyanagi M; Chikata T; Naruto T; Maruyama R; Tamura Y; Ishizuka N; Gatanaga H; Oka S; Takiguchi M
    J Virol; 2015 May; 89(10):5330-9. PubMed ID: 25741000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-clade immune responses to Gag p24 in patients infected with different HIV-1 subtypes and correlation with HLA class I and II alleles.
    Gudmundsdotter L; Bernasconi D; Hejdeman B; Sandstrom E; Alaeus A; Lidman K; Ensoli B; Wahren B; Buttò S
    Vaccine; 2008 Sep; 26(40):5182-7. PubMed ID: 18479789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-B molecules target more conserved regions of the HIV-1 proteome.
    Fontaine Costa AI; Rao X; Lechenadec E; van Baarle D; Keşmir C
    AIDS; 2010 Jan; 24(2):211-5. PubMed ID: 19904197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV immune escape at an immunodominant epitope in HLA-B*27-positive individuals predicts viral load outcome.
    Ammaranond P; van Bockel DJ; Petoumenos K; McMurchie M; Finlayson R; Middleton MG; Davenport MP; Venturi V; Suzuki K; Gelgor L; Kaldor JM; Cooper DA; Kelleher AD
    J Immunol; 2011 Jan; 186(1):479-88. PubMed ID: 21115730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic immune responses maintain cytotoxic T lymphocyte epitope mutations in transmitted simian immunodeficiency virus variants.
    Barouch DH; Powers J; Truitt DM; Kishko MG; Arthur JC; Peyerl FW; Kuroda MJ; Gorgone DA; Lifton MA; Lord CI; Hirsch VM; Montefiori DC; Carville A; Mansfield KG; Kunstman KJ; Wolinsky SM; Letvin NL
    Nat Immunol; 2005 Mar; 6(3):247-52. PubMed ID: 15685174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversion of immune escape HIV variants upon transmission: insights into effective viral immunity.
    Kent SJ; Fernandez CS; Dale CJ; Davenport MP
    Trends Microbiol; 2005 Jun; 13(6):243-6. PubMed ID: 15936652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic T-cell epitopes in HIV/SIV infection.
    Venet A; Walker BD
    AIDS; 1993; 7 Suppl 1():S117-26. PubMed ID: 7689848
    [No Abstract]   [Full Text] [Related]  

  • 17. The HIV hide and seek game: an immunogenomic analysis of the HIV epitope repertoire.
    Vider-Shalit T; Almani M; Sarid R; Louzoun Y
    AIDS; 2009 Jul; 23(11):1311-8. PubMed ID: 19550286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic T-cell recognition of HIV proteins and peptides.
    Nixon DF; McMichael AJ
    AIDS; 1991 Sep; 5(9):1049-59. PubMed ID: 1718319
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of human leukocyte antigen E and G in HIV infection.
    Tripathi P; Agrawal S
    AIDS; 2007 Jul; 21(11):1395-404. PubMed ID: 17589185
    [No Abstract]   [Full Text] [Related]  

  • 20. AIDS/HIV. Finding footprints among the trees.
    Klenerman P; McMichael A
    Science; 2007 Mar; 315(5818):1505-7. PubMed ID: 17363650
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.